DEADLINE ALERT for BAK and PROG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
September 04, 2020 10:00 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Sept. 04, 2020 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
SHAREHOLDER ALERT: Barr Law Group Investigating the Officers and Directors of NGHC, GOCO, PSTX, and PROG; Shareholders are Encouraged to Contact the Firm
September 03, 2020 09:00 ET
|
Barr Law Group
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- If you own any of the above stocks and would like to discuss your legal rights, please email leo@barrlaw.com or call (619) 400-4966. ...
Progenity to Participate in Two Upcoming Investor Conferences
September 02, 2020 07:30 ET
|
Progenity, Inc.
SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
PROGENITY ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Progenity, Inc. and Encourages Investors to Contact the Firm
August 31, 2020 11:20 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United...
PROGENITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Progenity, Inc. on Behalf of Progenity Stockholders and Encourages Investors to Contact the Firm
August 28, 2020 16:00 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 28, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Progenity, Inc. (NASDAQ:...
Progenity Commends New Recommendations from ACOG and SMFM Supporting Non-Invasive Prenatal Testing (NIPT) for All Pregnancies
August 21, 2020 07:30 ET
|
Progenity, Inc.
SAN DIEGO, Aug. 21, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Progenity Provides Corporate Updates and Reports Second Quarter 2020 Financial Results
August 13, 2020 16:01 ET
|
Progenity, Inc.
Completed initial public offering raising gross proceeds of $100M Reported 75 thousand tests in the second quarter, showing resiliency of business during COVID‑19 pandemic Signed first precision...
Progenity to Report Second Quarter 2020 Financial Results
August 06, 2020 16:05 ET
|
Progenity, Inc.
SAN DIEGO, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Progenity Reaches Resolution with Government Related to Past Business, Promotional, and Billing Practices
July 23, 2020 13:58 ET
|
Progenity, Inc.
SAN DIEGO, July 23, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company focused on providing complex molecular and specialized diagnostic tests to clinicians as well as...